Publications:

The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer.

Oncotarget

Coaxum, Sonya D SD; Tiedeken, Jessica J; Garrett-Mayer, Elizabeth E; Myers, Jeffrey J; Rosenzweig, Steven A SA; Neskey, David M DM

Publication Date: 2017-04-04

Variant appearance in text: N/A

PubMed Link: 28160562

Variant Present in the following documents:

View BVdb publication page

TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.

Ebiomedicine

Kandioler, Daniela D; Mittlböck, Martina M; Kappel, Sonja S; Puhalla, Harald H; Herbst, Friedrich F; Langner, Cord C; Wolf, Brigitte B; Tschmelitsch, Jörg J; Schippinger, Walter W; Steger, Günther G; Hofbauer, Friedrich F; Samonigg, Hellmut H; Gnant, Michael M; Teleky, Bela B; Kührer, Irene I; ,

Publication Date: 2015-08

Variant appearance in text: TP53: 612_613insA

PubMed Link: 26425688

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page